The efficacy of topiramate in the treatment of idiopathic intracranial hypertension (IIH) was compared to acetazolamide in an open-label study of 40 patients (age range 16-50, median 32 years; male/female ratio 5/35) at Ege University Medical School, Izmir, Turkey
Idiopathic intracranial hypertension (IIH) is a well-characterized syndrome, most commonly affecting...
Objective: Acetazolamide is preferred as the first-line drug for the medical treatment of idiopathic...
Summary: Idiopathic Intracranial Hypertension (IIH) • Increased intracranial pressure of an idiopath...
WOS: 000249990000008PubMed ID: 17922725Objectives - To assess the efficacy of topiramate in the trea...
Topiramate is approved for the treatment of epilepsy and migraine prophylaxis. It also actS as a car...
BACKGROUND The management of idiopathic intracranial hypertension focuses on reducing intracrania...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
The management of idiopathic intracranial hypertension (IIH) is focused on reducing ICP to try to bo...
The cause of Idiopathic intracranial hypertension (IIH) remains unknown and no consensus exists on h...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is a well-characterized syndrome, most commonly affecting...
Objective: Acetazolamide is preferred as the first-line drug for the medical treatment of idiopathic...
Summary: Idiopathic Intracranial Hypertension (IIH) • Increased intracranial pressure of an idiopath...
WOS: 000249990000008PubMed ID: 17922725Objectives - To assess the efficacy of topiramate in the trea...
Topiramate is approved for the treatment of epilepsy and migraine prophylaxis. It also actS as a car...
BACKGROUND The management of idiopathic intracranial hypertension focuses on reducing intracrania...
Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can re...
The NORDIC IIH treatment trial established new standards regarding the use and dosing of acetazolami...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
Idiopathic intracranial hypertension (IIH) is a potentially blinding disorder that typically affects...
The management of idiopathic intracranial hypertension (IIH) is focused on reducing ICP to try to bo...
The cause of Idiopathic intracranial hypertension (IIH) remains unknown and no consensus exists on h...
Idiopathic intracranial hypertension (IIH) is a common and potentially blinding disorder that affect...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is a disease of unknown etiology that occurs primarily in...
Idiopathic intracranial hypertension (IIH) is a well-characterized syndrome, most commonly affecting...
Objective: Acetazolamide is preferred as the first-line drug for the medical treatment of idiopathic...
Summary: Idiopathic Intracranial Hypertension (IIH) • Increased intracranial pressure of an idiopath...